| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/08/2006 | EP1041995B1 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
| 03/08/2006 | EP1038011B1 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
| 03/08/2006 | EP1005460B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 03/08/2006 | EP1003774B1 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6 |
| 03/08/2006 | EP0977568B1 Benzocycloheptathiophene compounds |
| 03/08/2006 | EP0938476B1 Process for substituted pyridines |
| 03/08/2006 | EP0870039B1 Recombinant fusion proteins to growth hormone and serum albumin |
| 03/08/2006 | EP0733109B1 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 03/08/2006 | CN1745080A 1,3-dihydroimidazole fused-ring compound |
| 03/08/2006 | CN1745074A 5-HT receptor ligands and uses thereof |
| 03/08/2006 | CN1745071A Novel ethylenediamine derivatives |
| 03/08/2006 | CN1745069A Mercaptoimidazoles as CCR2 receptor antagonists |
| 03/08/2006 | CN1745063A Compound inhibiting dipeptidyl peptidase iv |
| 03/08/2006 | CN1744917A Sustained-release pharmaceutical composition for lung administration |
| 03/08/2006 | CN1744916A Preventive or remedy for diseases caused by hyperglycemia |
| 03/08/2006 | CN1744910A Drugs containing galectin 9 |
| 03/08/2006 | CN1744906A Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method |
| 03/08/2006 | CN1744892A Breast cancer resistance protein (BCRP) inhibitor |
| 03/08/2006 | CN1744887A Breast cancer-resistant protein inhibitor |
| 03/08/2006 | CN1744879A Whitening agent, skin preparation for external use and cosmetic |
| 03/08/2006 | CN1743302A Arylpiperazines having 5-hydroxyl-typtamine activity |
| 03/08/2006 | CN1742981A Chinese medicine injecta preparing method for treating syncope |
| 03/08/2006 | CN1742980A Chinese medicinal lotion for new-borne baby's removing jaundice |
| 03/08/2006 | CN1742975A Paerpi pill |
| 03/08/2006 | CN1742953A Plant cell regulator |
| 03/08/2006 | CN1742940A Chinese medicine preparation for tonifying brain and calming nerves and anti-fatigue |
| 03/08/2006 | CN1742853A Compound medicine granulaes for treating entroendotoxinemia and preparing method |
| 03/08/2006 | CN1742791A Heat-clearing toxifying soft capsule and preparing method |
| 03/08/2006 | CN1742779A Gynostemma pentaphylla oral liquod |
| 03/08/2006 | CN1742739A Medicine formulation for left-eyed flounder and right-eyed flounder to prevent and control a scites |
| 03/08/2006 | CN1742717A Liquid medicine containing lucidril and preparing method |
| 03/08/2006 | CN1244589C 腺苷a3受体激动剂 A3 adenosine receptor agonists |
| 03/08/2006 | CN1244581C Method for producing anticholinergic agent substitute bromide |
| 03/08/2006 | CN1244580C Aminothiazoles and their use as adenosine receptor antagonists |
| 03/08/2006 | CN1244578C Substituted benzofuran-2-carboxamides derivatives |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/08/2006 | CN1244558C 1,2-hydrindene or indoline derivative |
| 03/08/2006 | CN1244369C Medicine for treating Sjogren syndrome and its preparing process |
| 03/08/2006 | CN1244329C Use of anti-pregnant-hormone for preparing medicine for inhibiting accelerated endometrial maturation of female mammals |
| 03/08/2006 | CN1244328C Medicine for preventives or remedies for diseases induced by hypofunction of nitric oxide synthase (NOS) |
| 03/08/2006 | CN1244326C Fatigue-resistant drug composition |
| 03/08/2006 | CN1244323C Novel fatty acid analogues for the treatment of primary and secondary restenosis |
| 03/08/2006 | CN1244322C Use of inhibitors of sodium-hydrogen exchanging pump for production of medicine for treatment of disorders which are caused by protozoa |
| 03/08/2006 | CN1244291C Soaking liquid for 'beggar chicken' |
| 03/07/2006 | US7009060 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 03/07/2006 | US7009053 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
| 03/07/2006 | US7009051 4-(2-pyridyl) piperazines having 5HT7 receptor agonist activity |
| 03/07/2006 | US7009049 Syntheses of quinazolinones |
| 03/07/2006 | US7008959 Preparing a novel crystal form by sonication and temperature oscillation of a suspension; filtered and dried faster; treating cardiovascular disorders |
| 03/07/2006 | US7008956 p53 inhibitors and therapeutic use of the same |
| 03/07/2006 | US7008955 (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists |
| 03/07/2006 | US7008952 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/07/2006 | US7008949 Antiinflammatory agents; antihistamines; Alzheimer's disease; anticholesterol agents; cardiovascular disorders; inflammatory bowel disorders; antitumor agents; antidiabetic agents; brain disorders; multiple sclerosis |
| 03/07/2006 | US7008947 Use to treat anxiety, depression, a sleep disorder such as primary insomnia, circadian rhythm sleep disorder, dyssomnia NOS, nightmare disorder, or attention deficit disorder |
| 03/07/2006 | US7008946 CCR5 antagonists useful for treating AIDS |
| 03/07/2006 | US7008945 Amide derivatives |
| 03/07/2006 | US7008943 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/07/2006 | US7008942 Cytotoxic agents comprising taxanes and their therapeutic use |
| 03/07/2006 | US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient |
| 03/07/2006 | US7008925 use for treatment of medical and veterinary conditions which can be influenced by the MC1-receptor; act as immunomodulators and to affect motivation, learning, memory, behaviour, inflammation, body temperature, pain, perception |
| 03/07/2006 | US7008922 Transplantation antigen that can lead to rejection of HLA-matched male organ and bone marrow grafts by female recipients, and may play a role in pregnancy and spermatogenesis. However, the origin and function of H-Y |
| 03/07/2006 | US7008920 comprising pharmacologically active substance, drug absorbefacient and taurine compound or polyamine; suppressing or preventing damage of the intestinal mucous membrane |
| 03/07/2006 | US7008791 Liposome-entrapped DNA oral vaccines |
| 03/07/2006 | US7008649 administering compositions of eugenol and forskolin; for treating and/or preventing soft tissue cancer in mammals |
| 03/07/2006 | US7008640 Mixture of drug, aminoacrylate polymer and acid |
| 03/07/2006 | US7008630 Controlling cell differentiation, cell proliferation; antiinflammatory agents; skin disorders |
| 03/07/2006 | US7008616 Ephedrine or fenfluramine; aluminum foil coated with a thin layer of drug is heated to form vapor; which condenses to form aerosol; rapid peak plasma concentration |
| 03/07/2006 | US7008615 Delivery of anti-migraine compounds through an inhalation route |
| 03/07/2006 | US7008444 Method of controlling body temperature while reducing shivering |
| 03/07/2006 | CA2245123C Use of rosaceae plant extract as a bradykinin antagonist |
| 03/02/2006 | WO2006023852A2 Modulators of muscarinic receptors |
| 03/02/2006 | WO2006022442A1 Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity |
| 03/02/2006 | WO2006022420A1 Preventives/remedies for stress urinary incontinence and method of screening the same |
| 03/02/2006 | WO2006022374A1 2-phenylpyridine derivative |
| 03/02/2006 | WO2006022340A1 Composite fine particles and process for producing the same |
| 03/02/2006 | WO2006022234A1 NFATc1 EXPRESSION INHIBITOR, OSTEOCLAST DIFFERENTIATION OR ACTIVATION INHIBITOR, AND PHARMACEUTICAL COMPOSITION |
| 03/02/2006 | WO2005079774A3 Management of ophthalmologic disorders, including macular degeneration |
| 03/02/2006 | WO2003031464A3 Remodeling and glycoconjugation of peptides |
| 03/02/2006 | WO2002072769A3 Human serpin polypeptides |
| 03/02/2006 | US20060047119 Analgesics with use of treating pain and as immunomodulators and for treatment of drug dependence |
| 03/02/2006 | US20060046992 Heterobicyclic compounds |
| 03/02/2006 | US20060046987 Substituted quinazoline derivatives and their use as inhibitors |
| 03/02/2006 | US20060046255 Use of nucleic acid analogues in diagnostics and analytical procedures |
| 03/02/2006 | US20060045874 Such as Hurler syndrome and Batten by administering an aminoglycosidesuch as gentamicin, G418, hygromycin B, paromomycin, tobramycin, lividomycin A, amikacin, sisomycin, or neomycin in combination with an enzyme effective for enzyme replacement therapy, a polyionic compound or gene therapy |
| 03/02/2006 | DE60108394T2 Sulfonyl-pyrrolidinderivate geeignet für die behandlung von neurologischen krankheiten Sulfonyl-pyrrolidine derivatives suitable for the treatment of neurological diseases |
| 03/02/2006 | DE19916896B4 Teilchen mit kleiner Dimension, die eine Wand aus einem Gemisch von vernetzten Proteinen und Polysacchariden aufweisen, die an der Oberfläche mit Metallionen chelatbildende Hydroxamgruppen enthalten, Verfahren zu ihrer Herstellung und ihre verschiedenen Verwendungen insbesondere in der kosmetischen, pharmazeutischen und Nahrungsmittelindustrie Particles having smaller dimensions, which have a wall composed of a mixture of cross-linked proteins, and polysaccharides containing on the surface with metal ions chelating hydroxamic groups, process for their preparation and to their different uses, particularly in the cosmetic, pharmaceutical and food industry |
| 03/02/2006 | CA2578168A1 2-phenylpyridine derivative |
| 03/02/2006 | CA2577677A1 Modulators of muscarinic receptors |
| 03/02/2006 | CA2576159A1 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
| 03/01/2006 | EP1630165A1 [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 03/01/2006 | EP1630162A1 2-aminoquinoline derivative |
| 03/01/2006 | EP1630157A1 CaSR ANTAGONIST |
| 03/01/2006 | EP1629853A1 Method for preparing powder exhibiting low susceptibility to electrification |
| 03/01/2006 | EP1629843A2 Reboxetine for treating chronic fatigue syndrome |
| 03/01/2006 | EP1629837A1 Antistress agent |
| 03/01/2006 | EP1629832A1 A pharmaceutical formulation comprising human growth hormone, an amino acid and a non-ionic detergent |
| 03/01/2006 | EP1628994A2 Method for identifying modulators of g protein coupled receptor signaling |
| 03/01/2006 | EP1628661A2 Modulators of vr1 receptor |
| 03/01/2006 | EP1628533A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/01/2006 | EP1472255B1 Aza-arylpiperazines |